WANBURY LIMITED Valuation

WANBURY · Healthcare · Current price ₹254.15

Full stock page
DocStoX fair value
₹266
low confidence
Current price
₹254
Upside
+4.7%
P/E ratio
13.4x
P/B ratio
6.2x
Verdict
Fairly Valued
Model it yourself — Earnings Yield Calculator
Opens pre-filled with WANBURY LIMITED's latest numbers.

Is WANBURY LIMITED undervalued?

DocStoX estimates the fair value of WANBURY LIMITED at ₹266 per share, versus the current market price of ₹254. That puts the stock about +4.7% below our fair-value estimate, which we read as "Fairly Valued". Our confidence in this estimate is low.

How this fair value is calculated

This estimate blends 3 independent methods: Residual income (₹149), Relative P/E (₹574), Graham floor (₹133). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.

Bear, base and bull scenarios

Our scenarios span ₹133 (bear) to ₹266 (base) to ₹574 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.

Valuation multiples

WANBURY LIMITED trades at a P/E of 13.4x and a P/B of 6.2x, with a dividend yield of 0.0%. Multiples are most useful compared against the company's own history and its sector peers — see the peer comparison for context.

Understand the ratios

P/E RatioP/B RatioPEG RatioEarnings Yield

More on WANBURY LIMITED

Fair ValueIntrinsic ValueDCFFinancial RatiosPeers

DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.